News | July 09, 2013

Diastolic Dysfunction Can Be Targeted to Lower Congestive Heart Failure Readmissions

Researchers analyzed nearly 2,000 congestive heart failure patients

July 9, 2013 — Researchers have announced the results of a study which shows that among patients readmitted for congestive heart failure (CHF), a high E/e’ (a measure of elevated left ventricle filling pressure via ultrasound) at admission is significantly associated with higher 30-day readmission rates.  Focusing on lowering elevated E/e’ levels will be important to control healthcare costs and to reduce the high rates of morbidity and mortality in this patient population.

“We are happy to report that we now have some clear indicators on who might be at most risk of being readmitted in this patient population,” said Manoj Bhandari, M.D., an investigator on the study.

Bhandari and his colleagues analyzed 1,907 CHF patients using echocardiography to check the predictive nature of various measurements and the E/e’ was found to be independently associated with higher readmission rates.

The study, "High Admission E/e’ Is Independently Associated With Higher 30-day Congestive Heart Failure Readmission Rate," was a poster presentation at the 2013 American Society of Echocardiography (ASE) Annual Scientific Sessions.

For more information: www.asecho.org


Additional Content

News | Cardiovascular Clinical Studies

Nov. 1, 2026 – Abbott has announced the 30-day results from the TECTONIC Coronary Artery Disease (CAD) Intravascular ...

Home November 03, 2026
Home
News | Cardiovascular Clinical Studies

Oct. 27, 2026 — Atrium Therapeutics, developer of RNA therapeutics targeted to the heart, has announced that the first ...

Home October 30, 2026
Home
News | Cardiovascular Clinical Studies

Oct. 1, 2026 — W. L. Gore & Associates’ medical business (Gore) has announced the first patient enrollment in the IBE ...

Home October 01, 2026
Home
News | Cardiovascular Clinical Studies

Aug. 31, 2026 — Amgen has announced new findings showing Repatha (evolocumab) reduced the risk of death in high-risk ...

Home September 02, 2026
Home
News | Cardiovascular Clinical Studies

Aug. 20, 2026 — A new study found that nearly 8 out of 10 young adult participants, average age 23 years, had ...

Home August 21, 2026
Home
Subscribe Now